Literature DB >> 2480848

Effect of anticancer drugs on the release of interferon gamma in vitro.

K Ahmed1, P H van der Meide, J L Turk.   

Abstract

Some conventional and experimental anti-cancer drugs were tested for their effect on concanavalin-A-induced interferon gamma release from rat splenocytes in vitro. When 2.5 x 10(6) rat splenocytes/ml, stimulated with 1 microgram/ml concanavalin A, were incubated with various non-cytotoxic doses of the vinca alkaloid vincristine, there was an inhibition of the release of interferon gamma in culture supernatants. The antitumour antibiotics bleomycin and Adriamycin, alkylating agents 4-hydroperoxycyclophosphamide and mafosfamide, and the immunoactive peptides FK156 and FK565 did not affect the release of interferon gamma under similar conditions. However, cyclosporin A, in similar experiments, markedly inhibited the release of interferon gamma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480848     DOI: 10.1007/bf01665007

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  28 in total

1.  Fluorescent labeling of hormone receptors in viable cells: preparation and properties of highly fluorescent derivatives of epidermal growth factor and insulin.

Authors:  Y Shechter; J Schlessinger; S Jacobs; K J Chang; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

2.  Potentiation of release of interleukin-2 by bleomycin.

Authors:  T A Abdul Hamied; D Parker; J L Turk
Journal:  Immunopharmacology       Date:  1986-10

3.  Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.

Authors:  K Ahmed; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Production of immune interferon by murine T-cell clones from long-term cultures.

Authors:  F Marcucci; M Waller; H Kirchner; P Krammer
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

5.  Identification of the T cell subset that produces human gamma interferon.

Authors:  J A O'Malley; A Nussbaum-Blumenson; D Sheedy; B J Grossmayer; H Ozer
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

6.  The differential sensitivity of T cell immune functions to vincristine and vinblastine.

Authors:  K Ryoyama; K Mace; M J Ehrke; E Mihich
Journal:  Int J Immunopharmacol       Date:  1982

Review 7.  Molecular characterization of interleukin 2.

Authors:  S Gillis; D Y Mochizuki; P J Conlon; S H Hefeneider; C A Ramthun; A E Gillis; M B Frank; C S Henney; J D Watson
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

8.  Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.

Authors:  R Keller; R Keist; P H Van der Meide; P Groscurth; M Aguet; T P Leist
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

9.  Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.

Authors:  N Weissmann; G Leyhausen; A Maidhof; W Tanaka; H Umezawa; W E Müller
Journal:  J Antibiot (Tokyo)       Date:  1985-06       Impact factor: 2.649

10.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  2 in total

1.  Effect of anticancer drugs on the release of interleukin-6 in vitro.

Authors:  S I Hasan; B A Blaney; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function.

Authors:  R Sorrentino; P M de Souza; S Sriskandan; C Duffin; M J Paul-Clark; J A Mitchell
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.